chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 38.0
Sex: M
Vaccine: HEPA
Symptoms: Culture, Haematocrit decreased, Incisional drainage, Injection site induration, Injection site pain
Clinical narrative: Pt is a 38-year-old male who is seen in consultation for Dr. for evaluation of left arm lesion. Patient states he received a hepatitis A vaccine injection in his left arm on 10/8/18. Patient states that 3 weeks after the injection, he began having fevers twice a week ranging from 99-101°F. Patient states he noticed a hard area on his left upper extremity at the site of the injection. States this area has been increasing in size. Rates pain of left upper extremity at injection site 4/10. States the pain is worse when he raises his arm. Denies redness or drainage. Patient had ultrasound on 1/4/19 which revealed the following: Scanning of the left upper arm where the patient complains of a palpable abnormality reveals a somewhat poorly defined hypoechoic subcutaneous lesion measuring 9 x 3 mm suspicious for developing abscess; there is increased blood flow at the periphery of this abnormality; this is in the subcutaneous fat, superficial to the musculature. Laboratory studies on 1/4/19 reveal CMP within normal limits except for total protein elevated at 8.3, CBC within normal limits except for hematocrit low at 38.4. I&D Left arm. Wet-to-dry dressing BID. Cultures obtained.
Age: 38.0
Sex: M
Vaccine: HEPA
Symptoms: Injection site reaction, Pain, Protein total increased, Pyrexia, Skin lesion
Clinical narrative: Pt is a 38-year-old male who is seen in consultation for Dr. for evaluation of left arm lesion. Patient states he received a hepatitis A vaccine injection in his left arm on 10/8/18. Patient states that 3 weeks after the injection, he began having fevers twice a week ranging from 99-101°F. Patient states he noticed a hard area on his left upper extremity at the site of the injection. States this area has been increasing in size. Rates pain of left upper extremity at injection site 4/10. States the pain is worse when he raises his arm. Denies redness or drainage. Patient had ultrasound on 1/4/19 which revealed the following: Scanning of the left upper arm where the patient complains of a palpable abnormality reveals a somewhat poorly defined hypoechoic subcutaneous lesion measuring 9 x 3 mm suspicious for developing abscess; there is increased blood flow at the periphery of this abnormality; this is in the subcutaneous fat, superficial to the musculature. Laboratory studies on 1/4/19 reveal CMP within normal limits except for total protein elevated at 8.3, CBC within normal limits except for hematocrit low at 38.4. I&D Left arm. Wet-to-dry dressing BID. Cultures obtained.
Age: 38.0
Sex: M
Vaccine: HEPA
Symptoms: Ultrasound scan abnormal
Clinical narrative: Pt is a 38-year-old male who is seen in consultation for Dr. for evaluation of left arm lesion. Patient states he received a hepatitis A vaccine injection in his left arm on 10/8/18. Patient states that 3 weeks after the injection, he began having fevers twice a week ranging from 99-101°F. Patient states he noticed a hard area on his left upper extremity at the site of the injection. States this area has been increasing in size. Rates pain of left upper extremity at injection site 4/10. States the pain is worse when he raises his arm. Denies redness or drainage. Patient had ultrasound on 1/4/19 which revealed the following: Scanning of the left upper arm where the patient complains of a palpable abnormality reveals a somewhat poorly defined hypoechoic subcutaneous lesion measuring 9 x 3 mm suspicious for developing abscess; there is increased blood flow at the periphery of this abnormality; this is in the subcutaneous fat, superficial to the musculature. Laboratory studies on 1/4/19 reveal CMP within normal limits except for total protein elevated at 8.3, CBC within normal limits except for hematocrit low at 38.4. I&D Left arm. Wet-to-dry dressing BID. Cultures obtained.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Injection site reaction, Rash vesicular
Clinical narrative: Bumpy blister rash at injection site.
Age: 26.0
Sex: F
Vaccine: HPV9
Symptoms: Headache
Clinical narrative: Headaches lasting longer than 2 days. Injection on 1/3/19, headache started 1/4/19, as of today 1/8/19, headache persists.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Rash
Clinical narrative: I BROKE OUT WITH A SEVERE RASH A FEW DAYS AFTER TAKING THE FIRST PART OF THE SHINGRIX VACCINE. I ENDED GOING TO MY PRIMARY DR. ON THURSDAY, DEC. 27TH. SHE GAVE ME ANTIBIOTICS. I HAD TO RETURN TO A URGENT CARE ON SUNDAY, DEC. 30TH 2018. THE DR. THERE GAVE ME AN OINTMENT. RASH IS MUCH BETTER. TODAY IS TUESDAY, JAN. 8TH 2019 AND I STILL ITCH A LITTLE. IT IS MUCH BETTER. NEEDLESS TO SAY I WILL NOT TAKE 2ND PART OF THE VACCINE.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Mobility decreased, Pain, Swelling
Clinical narrative: About and hour and a half after receiving the vaccination I noticed swelling, redness and pain.  Over the next hour the pain became intolerable. I couldn't move my shoulder at first, then couldn't move my entire arm down to the fingers. Went to the emergency room. I was there about 8 hours. I received pain medicine. Over 3 weeks later. My arm looks normal. I continue to have pain, but not nearly as severe.
Age: 7.0
Sex: M
Vaccine: FLU4
Symptoms: Crying, Dizziness, Headache, Pain in extremity
Clinical narrative: Telephone call from client's mother stating around 5:00 PM the evening of the receipt of the vaccine the child began to cry and c/o his arm hurting. This was during the mother's physician visit, and upon returning to their home, she took the child's temperature. Temperature at 6:30 PM was 103 F. At this time, the child was crying more intensely and c/o left arm pain. Child also c/o headache and dizziness. Mother states his c/o of arm pain was unusually painful the night of the vaccine. This continued throughout the evening; the child's pediatrician's office was closed and local Urgent Care Centers were closing. The mother took the child to the emergency room. Assessment was conducted, stated no anaphylaxis, no throat swelling, no dyspnea. Mother states the following day, January 4, 2019, the symptoms had resolved. She contacted the child's pediatrician as instructed by the ER physician. Related the events to his PMD who indicated he considered this an allergic reaction, he was making a note on the child's chart, and the child can never have the flu vaccine again. The mother had consulted the VIS and understood a temperature of 103 would be considered a severe reaction to the vaccine. States child has had flu vaccine in the past without issue.
Age: 42.0
Sex: M
Vaccine: HEPA
Symptoms: Culture, Incisional drainage, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Patient is a 43-year-old male who is seen in consultation for Dr. for evaluation of left arm lesion. Patient had hepatitis A vaccination injection on 10/8/18. States at the site of injection in his left upper extremity, he noticed swelling and tenderness 3 weeks ago. Rates pain 2/10. Reports erythema and warmth to touch at the site of injection in his left upper extremity. Denies drainage, fever, sweats, chills. I&D Left arm. Wet-to-dry dressings BID. Cultures obtained.
Age: 42.0
Sex: M
Vaccine: HEPA
Symptoms: Injection site warmth, Pain, Skin lesion
Clinical narrative: Patient is a 43-year-old male who is seen in consultation for Dr. for evaluation of left arm lesion. Patient had hepatitis A vaccination injection on 10/8/18. States at the site of injection in his left upper extremity, he noticed swelling and tenderness 3 weeks ago. Rates pain 2/10. Reports erythema and warmth to touch at the site of injection in his left upper extremity. Denies drainage, fever, sweats, chills. I&D Left arm. Wet-to-dry dressings BID. Cultures obtained.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Dizziness, Syncope
Clinical narrative: Vaccines administered while child sitting in a chair. Several minutes after receiving the vaccine, he stood up suddenly, then fainted. He was lifted to a chair and awake in seconds. He told his mother that the last shot (MENVEO) made him dizzy. He had told the nurse several minutes before he stood up that he was fine. The precise time that he received the vaccine and the precise number of minutes before he fainted is not known.
Age: 1.0
Sex: M
Vaccine: FLU4, HEPA, MMR, VARCEL
Symptoms: Febrile convulsion, Upper respiratory tract infection
Clinical narrative: Pt presented to the ED with febrile seizure one day after receiving vaccines, lasted 3 minutes, was at neuro baseline in ED, febrile in ED.
Age: 8.0
Sex: F
Vaccine: HPV9
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: HPV given in error.
Age: 1.5
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Feeling abnormal, Pneumonia, Pyrexia, X-ray
Clinical narrative: Pneumonia- fever as high as 105 without meds, motrin barely brought it down to 104. High fevers lasted a little over 24 hours. After 2 doses of Antibiotics patient showed signs of imrovement. Day four and patient is still riding the wave of feeling good then bad.
Age: 54.0
Sex: M
Vaccine: PPV, VARZOS
Symptoms: Blood test, Erythema, Injection site erythema, Pyrexia
Clinical narrative: I had two vaccines in the same arm (right) very close together. PNEUMOVAX and Shingles. The next day, there was redness around the injection site and I ran a fever of 103 degrees. PCP sent me to ER. Was treated with IV antibiotics and released. The next day, there was additional redness and streaking up the arm and into the chest. I went back to the ER and was admitted overnight. Treated with strong IV antibiotics.
Sex: U
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Chills, Headache, Myalgia, Pyrexia
Clinical narrative: Muscle pain, headache, shivering, slight fever, digestive upset.
Age: 73.0
Sex: F
Vaccine: FLU4
Symptoms: Loss of consciousness, Muscular weakness
Clinical narrative: Extreme muscle weakness, passing out.
Age: 23.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Erythema, Injected limb mobility decreased, Pain in extremity, Peripheral swelling, Skin warm
Clinical narrative: Left arm became painful, swollen, red, and warm to touch, unable to move arm. Right arm red and swollen as well but became better.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Chest pain, Dizziness, Heart rate increased, Injection site erythema, Injection site swelling
Clinical narrative: Patient experienced extreme redness and swelling at injection site during the night she got the vaccine (12/28/18). She had muscle pain throughout her entire body. When she woke up the next day she had extreme vertigo and could not function. She experienced rapid heart rate, chest pains and palpitations and the dizziness became worse during 12/19. She went to the ER where they gave her IV fluids and also a dose of ketorolac 30mg IV push and was discharged. She was still experiencing vertigo and went to her doctor on 1/2/19 and there she received another steroid shot. Patient did not experience full recovery until 1/8/19.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Loss of personal independence in daily activities, Myalgia, Palpitations, Vertigo
Clinical narrative: Patient experienced extreme redness and swelling at injection site during the night she got the vaccine (12/28/18). She had muscle pain throughout her entire body. When she woke up the next day she had extreme vertigo and could not function. She experienced rapid heart rate, chest pains and palpitations and the dizziness became worse during 12/19. She went to the ER where they gave her IV fluids and also a dose of ketorolac 30mg IV push and was discharged. She was still experiencing vertigo and went to her doctor on 1/2/19 and there she received another steroid shot. Patient did not experience full recovery until 1/8/19.
Age: 1.0
Sex: M
Vaccine: PNC13, VARCEL
Symptoms: Rash maculo-papular, Scab
Clinical narrative: Various stages of maculopapular rash some with crusts.
Age: 22.0
Sex: F
Vaccine: HEPA
Symptoms: Pruritus, Rash
Clinical narrative: PATIENT HAS RASH WITH ITCHING ON BOTH ARMS.
Age: 51.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Pain, Pyrexia, Tremor
Clinical narrative: Fever (~103.5 degrees F, 12.5 hours after administration), body aches, shakes. Fever 102.2 15 hours after admin, headache. Fever 100.5 20+ hours after admin, headache.
Age: 69.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Immediate post-injection reaction, Injected limb mobility decreased, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Pain at onset and has increased each day. Site is swollen and red with pain going up through shoulder. Lost of mobility and strength in left arm.
Age: 69.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Muscular weakness, Pain
Clinical narrative: Pain at onset and has increased each day. Site is swollen and red with pain going up through shoulder. Lost of mobility and strength in left arm.
Age: 69.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Computerised tomogram, Immediate post-injection reaction, Injected limb mobility decreased, Injection site pain, Joint injection
Clinical narrative: Pain at onset and has increased each day. Site is swollen and red with pain going up through shoulder. Lost of mobility and strength in left arm.
Age: 69.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Loss of personal independence in daily activities, Nerve injury, Nuclear magnetic resonance imaging, Product administered at inappropriate site, Weight bearing difficulty
Clinical narrative: Pain at onset and has increased each day. Site is swollen and red with pain going up through shoulder. Lost of mobility and strength in left arm.
Age: 69.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Wrong technique in product usage process, X-ray limb
Clinical narrative: Pain at onset and has increased each day. Site is swollen and red with pain going up through shoulder. Lost of mobility and strength in left arm.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient's healthcare provider recommended, and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2012, a pharmacist administered ZOSTAVAX, (lot# and route unknown) to the patient. The patient was inoculated with the ZOSTAVAX vaccine to obtain permanent prevention and protection against shingles and zoster-related injuries. In February 2015, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. The patient used the ZOSTAVAX vaccine for the permanent prevention of shingles and zoster-related injuries. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider(s) recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2016, a healthcare provider at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 28-DEC-2016, the patient was treated by a physician/MD at a healthcare facility for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Causality assessment considered events to be related to the use of ZOSTAVAX. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider(s) recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2016, a healthcare provider at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In 2017, the patient was treated by a physician/MD at a healthcare facility/office for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Causality assessment considered events to be related to the use of ZOSTAVAX. Additional information has been requested.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Erythema, Herpes zoster, Skin lesion
Clinical narrative: Information has been received from a 67 year old female with latex allergy who on 28-JUN-2009 (The patient also stated she did receive the zoster vaccine live (Oka/Merck) vaccine last year.) was vaccinated with zoster vaccine live (Oka/Merck) (dose, route and site not reported). Concomitant therapy included omeprazole and oxybutynin. The patient stated that she had shingles since 28-JAN-2010. The patient's shingles persisted. It was unknown if the patient sought medical attention. Follow up information has been received from the consumer who reported that she was seen by her Doctor on 02-FEB-2010, who was aware of her shingles because the Doctor prescribed the vaccination. The patient stated that she was 8 weeks out from the outbreak of lesions. The blisters were gone, but the areas remained quite red and visible. The patient stated that she was progressing. Follow up information has been received on 02-JAN-2018 regarding a case in litigation from a lawyer. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 08-JUN-2009 (previously reported as 28-JUN-2009), a pharmacist at a pharmacy administered the ZOSTAVAX (lot number, expiration, dose and route unknown) to the patient. In 2010, the patient was treated by a healthcare provider at a physician's office for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The causality of the events is related. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Extra dose administered
Clinical narrative: Initial information received on 02-Jan-2019 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 11 years old male patient who received vaccine MENACTRA. The patients past medical history, concomitant medication and family history were not provided. On 07-Nov-2009, the patient received a first dose of suspect MENACTRA lot number, expiry date not reported via unknown route in unknown administration site. 2 other doses were administered on 21-Nov-2012 and again on 20-Dec-2015 for suspect MENACTRA. It was an actual medication error due to extra dose administered. It was asked by nurse if patient Should be MENACTRA be given to a 11-12-year-old adolescent who previously received MENACTRA before the 10th birthday. Child received at another practice meningococcal vaccine on 07-Nov-2009, on 21-Nov-2012 and again on 20-Dec-2015. It was unknown whether patient experienced any adverse reaction after the injection. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender- none.
Age: 53.0
Sex: F
Vaccine: FLU4
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Initial information received on 03-Jan-2019 regarding an unsolicited valid non-serious case received from a nurse. This case is linked to case 2019SA004380. This case involves a 53 years old female patient who received 1ml instead of a 0.5ml of vaccine FLUZONE QUADRIVALENT (Multidose Vial lot number: UJ009AA, expiry date: 30-Jun-2019) via unknown route in right deltoid on 02-Jan-2019. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided. It was a case of actual medication error due to overdose. It was reported that no side effects after the injection. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by sender: none.
Age: 75.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site pain, Musculoskeletal pain
Clinical narrative: Initial information received on 03-Jan-2019 regarding an unsolicited valid non-serious case received from a pharmacist by phone. This case involves a 75 years old male patient who experienced shoulder was hurting and was complaining more up in the shoulder to shoulder blade area, while he received vaccine FLUZONE HIGH DOSE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were not reported. On 23-Nov-2018, the patient received a 0.5 ml dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (lot number: UJ047AA and expiry date: 28-May-2019) via intramuscular route in the left deltoid. On 23-Nov-2018, the patient's shoulder was hurting and was complaining more up in the shoulder to shoulder blade area following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. Other relevant tests included No Lab data was reported. Patient was given ice pack as a corrective treatment. Final diagnosis was shoulder was hurting and was complaining more up in the shoulder to shoulder blade area. The patient outcome is reported as Unknown for shoulder was hurting and was complaining more up in the shoulder to shoulder blade area. Documents held by the sender: none.
Age: 18.0
Sex: F
Vaccine: FLU4
Symptoms: Immediate post-injection reaction, Injection site pain, Injection site reaction, Mobility decreased, Muscle spasms
Clinical narrative: Immediate pain and cramping from the site running down to the hand. Pain and cramping continued into 01/05/2019 and then mild Shaking of the hand also started. The pain continued, but the shaking stopped by the days end. Pain and stiffness got worse on 01/06/2019 and the hand became significantly weak. Unable to move arm due to severity of pain. Pain and stiffness and weakness  remained 01/07/2019 and has not resolved as of 01/08/2019.
Age: 18.0
Sex: F
Vaccine: FLU4
Symptoms: Muscular weakness, Musculoskeletal stiffness, Tremor
Clinical narrative: Immediate pain and cramping from the site running down to the hand. Pain and cramping continued into 01/05/2019 and then mild Shaking of the hand also started. The pain continued, but the shaking stopped by the days end. Pain and stiffness got worse on 01/06/2019 and the hand became significantly weak. Unable to move arm due to severity of pain. Pain and stiffness and weakness  remained 01/07/2019 and has not resolved as of 01/08/2019.
Age: 65.0
Sex: F
Vaccine: TDAP
Symptoms: Chills, Feeling abnormal, Injection site erythema, Injection site induration, Injection site pain
Clinical narrative: She started feeling crummy yesterday, developed chills, body aches and subj fevers. Then noted that her arm was quite red at the site of the injection. This redness has gotten worse today, firm and tender. She continues to feel feverish, chills. Some nausea, but no vomiting. cephalexin  500 mg capsule.
Age: 65.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site warmth, Nausea, Pain, Pyrexia
Clinical narrative: She started feeling crummy yesterday, developed chills, body aches and subj fevers. Then noted that her arm was quite red at the site of the injection. This redness has gotten worse today, firm and tender. She continues to feel feverish, chills. Some nausea, but no vomiting. cephalexin  500 mg capsule.
Age: 33.0
Sex: F
Vaccine: UNK
Symptoms: Hypoaesthesia, Injection site pain, Pain in extremity, Paraesthesia
Clinical narrative: I started to have left arm pain and it felt like my arm was going numb, and it was tingling. It got worse as the night went on and I was starting to get concerned and think maybe I was having a heart attack, but I was not having any other warning signs, and I am healthy. The pain felt like it was deep in my arm, not on the surface, and it was my whole arm at the injection site. It was even worse in the morning and I finally took TYLENOL at 11am that day and the pain went away about an hour later.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Headache, shivering, aches, slight fever throughout the night until about 5 AM 12/06/2018.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Nausea, Pyrexia
Clinical narrative: Fever, chills, nausea for 18 hours.
Age: 44.0
Sex: M
Vaccine: PPV
Symptoms: Cough, Fatigue, Hypersomnia, Influenza A virus test negative, Influenza B virus test
Clinical narrative: PNEUMOVAX 23 administered to the left deltoid on 12/29/18. Patient started to developed fatigue by the end of the following day (12/30) and essentially slept through the late afternoon/evening, skipping dinner. He was seen in the office on 12/31, was afebrile in the office but reported he had a fever of 101.9 the night before. Physical examination was notable for left deltoid injection site swelling and tenderness, without erythema. He also reported a cough and sore throat. Strep A and Influenza A/B rapid tests were negative. He was advised to use Acetaminophen for fever and to increase fluid intake.  When seen on 1/2/19, he reported feeling better but had slept for nearly 2 days (from 12/31/18 - 1/1/19) and that he develops a rash at the left deltoid injection site, which upon examination was a 2 x 3 cm area of erthyema, without induration, and left deltoid swelling had resolved. The fever, extreme fatigue, and left arm rash has all since resolved by 1/4.
Age: 44.0
Sex: M
Vaccine: PPV
Symptoms: Influenza virus test negative, Injection site erythema, Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: PNEUMOVAX 23 administered to the left deltoid on 12/29/18. Patient started to developed fatigue by the end of the following day (12/30) and essentially slept through the late afternoon/evening, skipping dinner. He was seen in the office on 12/31, was afebrile in the office but reported he had a fever of 101.9 the night before. Physical examination was notable for left deltoid injection site swelling and tenderness, without erythema. He also reported a cough and sore throat. Strep A and Influenza A/B rapid tests were negative. He was advised to use Acetaminophen for fever and to increase fluid intake.  When seen on 1/2/19, he reported feeling better but had slept for nearly 2 days (from 12/31/18 - 1/1/19) and that he develops a rash at the left deltoid injection site, which upon examination was a 2 x 3 cm area of erthyema, without induration, and left deltoid swelling had resolved. The fever, extreme fatigue, and left arm rash has all since resolved by 1/4.
Age: 44.0
Sex: M
Vaccine: PPV
Symptoms: Oropharyngeal pain, Pyrexia, Streptococcus test negative
Clinical narrative: PNEUMOVAX 23 administered to the left deltoid on 12/29/18. Patient started to developed fatigue by the end of the following day (12/30) and essentially slept through the late afternoon/evening, skipping dinner. He was seen in the office on 12/31, was afebrile in the office but reported he had a fever of 101.9 the night before. Physical examination was notable for left deltoid injection site swelling and tenderness, without erythema. He also reported a cough and sore throat. Strep A and Influenza A/B rapid tests were negative. He was advised to use Acetaminophen for fever and to increase fluid intake.  When seen on 1/2/19, he reported feeling better but had slept for nearly 2 days (from 12/31/18 - 1/1/19) and that he develops a rash at the left deltoid injection site, which upon examination was a 2 x 3 cm area of erthyema, without induration, and left deltoid swelling had resolved. The fever, extreme fatigue, and left arm rash has all since resolved by 1/4.
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling to the injection sight.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Pain in extremity
Clinical narrative: Patient claims soreness in arm over one month since receiving injection. Unsure if related to fibromyalgia or arthritis, but claims could raise arm over and behind head prior to injection and can no longer do so. Has not seeked medical attention. Claims that shot was given midway from shoulder to elbow.
Age: 78.0
Sex: F
Vaccine: FLUA3
Symptoms: Immediate post-injection reaction, Injection site pain, Pain
Clinical narrative: Pt described a sharp pain evident immediately upon injection into the deltoid. It hurts arm to lift, feels better if not moved. Pt going to put on compress and go home. Pain is not a dull pressure typical of vaccinations. Arm is mobile as of, 6:15pm.
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Erythema multiforme, Injection site reaction, Rash generalised, Rash macular, Skin discolouration
Clinical narrative: 48 hours after vaccinations, pt developed splotchy red rashes beginning under armpits, thighs (at injection area), on the face, and back of his neck. At noon we visited the pediatrician whom suggested it could be a coincidental viral rash, food allergy (exclusively breastfed), or unlikely reaction to the vaccination. Three hours later the rash continues to spread and causes purple discoloration of hands and feet. We take pt to the ER and though his vitals seem fine, the rash has spread all over his body. We are sent home with an ointment. The next day, splotches turn into rings and pediatrician gives the diagnosis as erythema multiforme, pt continues to have purplish hands and feet intermittently. The rashes seem to subside thereafter with occasional hives to a lesser degree throughout the next month. His skin clears up completely in May.
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Urticaria
Clinical narrative: 48 hours after vaccinations, pt developed splotchy red rashes beginning under armpits, thighs (at injection area), on the face, and back of his neck. At noon we visited the pediatrician whom suggested it could be a coincidental viral rash, food allergy (exclusively breastfed), or unlikely reaction to the vaccination. Three hours later the rash continues to spread and causes purple discoloration of hands and feet. We take pt to the ER and though his vitals seem fine, the rash has spread all over his body. We are sent home with an ointment. The next day, splotches turn into rings and pediatrician gives the diagnosis as erythema multiforme, pt continues to have purplish hands and feet intermittently. The rashes seem to subside thereafter with occasional hives to a lesser degree throughout the next month. His skin clears up completely in May.
Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Cervical vertebral fracture, Dizziness, Loss of consciousness, Road traffic accident
Clinical narrative: Patient stated she got dizzy while she was exercising on Thursday 1/4/19. She stopped and sat down for a minute. She got back up and continued to work out. As she was going home after class, she had a wreck in her car. She passed out.
Age: 31.0
Sex: F
Vaccine: MMR
Symptoms: Vision blurred
Clinical narrative: PT TOOK A SHORT NAP AFTER VACCINATION AT 9:42AM AND WOKE UP WITH BLURRY VISION THAT HAD NOT RESOLVED WHEN SHE CALLED US (AT APPROXIMATELY 12:30PM). RECOMMENDED DR'S VISIT IF IT DIDN'T RESOLVE SOON, PT SOUNDED LIKE SHE WAS GOING TO GO TO URGENT CARE.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain, Pain
Clinical narrative: Pt had adverse reaction to 1st SHINGRIX. She said staff injected shot more towards the back side of the deltoid rather than right in the middle of the deltoid. She said he must have hit a nerve in her left arm because lifting her arm is painful. The pain started a couple days after she received the shot. The pain traveled from shoulder down to elbow. Pt states it is better now but still painful.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Rash, Urticaria
Clinical narrative: Severe hives, rash on neck, Chest, and left arm with tiredness. CALLED DR. Advised BENADRYL, to come in if not improved. Not to get second shot.
Age: 1.75
Sex: M
Vaccine: VARCEL
Symptoms: Blood test normal, Electrocardiogram, Electroencephalogram normal, Seizure, Sleep study normal
Clinical narrative: My son was administered the Hep B vaccination by pharmaceutical company GlaxoSmithKline (lot no. 9Z924) on Tuesday 4/25/2017 and suffered 2 seizures on 4/27/2017. He was about 2.5 months at the time (born 2/17/17). I was advised by his Dr at the time to have him checked by the hospital and we were admitted to hospital on 4/29/2017. After extensive EEG testing, all results showed that he was healthy. He was given a second dose of Hep B vaccination on 08/02/17 by pharmaceutical company GlaxoSmithKlein (lot no. PN595) and suffered a seizure 2 days later. I was advised by his pediatrician  to bring my son to another Dr who ordered an overnight sleep study, which again showed healthy results. He was given the Varicella vaccination on 12/04/2018. The pharmaceutical company used was Merck & Co lot no. R018144. He had his 4th seizure of his life on 12/17/18. After which a full blood work panel was done which came back healthy. Dr ordered another EEG done on 1/3/2019 which came back with healthy results. My son has no medical diagnosis and he does not have any history of febrile seizures. He has had fevers with no seizure and the seizures he has had did not follow a high fever. His seizures are isolated incidents which leads me to believe that his body reacted to an ingredient in the vaccination.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Influenza, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Sore arm, redness, swelling and itching at injection site. Lasted several days (about 4) Fever, aches and flu symptoms - Lasted 12 hours.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Pyrexia
Clinical narrative: Sore arm, redness, swelling and itching at injection site. Lasted several days (about 4) Fever, aches and flu symptoms - Lasted 12 hours.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Vaccination site induration, Vaccination site swelling
Clinical narrative: Swelling, induration at vaccine site.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Hyperaesthesia, Pain in extremity, Rash, Sensitive skin
Clinical narrative: June 7: pt received injection. June 7-9: extremely sore arm. June 13: skin sensitivity on right waist and right upper thigh. June 14: Pain and sensitivity increased significantly, rash appears on upper thigh, difficulty tolerating clothing touching waist and upper thigh. Pt took ibuprofen twice daily to control pain. June 15-16: rash becomes worse. June 21: rash and pain start to diminish. June 28: rash and pain are gone. Pictures of rash were shown to internist who agreed that the rash was a shingles rash.
Age: 29.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Dizziness, Electrocardiogram T wave amplitude decreased, Electrocardiogram abnormal, Myocardial necrosis marker increased, Palpitations
Clinical narrative: Palpitations and dizziness, elevate cardiac enzymes.
Age: 29.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Troponin I increased
Clinical narrative: Palpitations and dizziness, elevate cardiac enzymes.
Age: 29.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Anxiety, Blood creatine phosphokinase increased, Blood thyroid stimulating hormone normal, Brain natriuretic peptide normal, Chest X-ray normal
Clinical narrative: Palpitations and dizziness, elevate cardiac enzymes.
Age: 29.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Chest pain, Dizziness, Drug screen negative, Dyspnoea, Echocardiogram abnormal
Clinical narrative: Palpitations and dizziness, elevate cardiac enzymes.
Age: 29.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Electrocardiogram T wave abnormal, Electrocardiogram abnormal, Extrasystoles, Fear, Feeling abnormal
Clinical narrative: Palpitations and dizziness, elevate cardiac enzymes.
Age: 29.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Fibrin D dimer normal, Full blood count normal, Heart rate increased, Heart rate irregular, Hyperhidrosis
Clinical narrative: Palpitations and dizziness, elevate cardiac enzymes.
Age: 29.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Hypoacusis, Lipids normal, Loss of consciousness, Malaise, Metabolic function test normal
Clinical narrative: Palpitations and dizziness, elevate cardiac enzymes.
Age: 29.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Myalgia, Myocarditis, Nuclear magnetic resonance imaging abnormal, Nuclear magnetic resonance imaging heart, Palpitations
Clinical narrative: Palpitations and dizziness, elevate cardiac enzymes.
Age: 29.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: QRS axis abnormal, Red blood cell sedimentation rate normal, Sinus rhythm, Syncope, Troponin I increased
Clinical narrative: Palpitations and dizziness, elevate cardiac enzymes.
Age: 29.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Tunnel vision, Ventricular extrasystoles, Visual impairment
Clinical narrative: Palpitations and dizziness, elevate cardiac enzymes.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Pyrexia
Clinical narrative: Intense shivering from 9:00-9:30 PM day of injection; fever from 5:10 PM day of injection until about 7 PM day after injection (ranging from 100.5-101 before beginning to drop late the next day after injection). One dose of ibuprofen was taken at 9 AM the morning after injection. All symptoms were gone by 7 PM the day after the injection.
Age: 40.0
Sex: F
Vaccine: TDAP
Symptoms: Joint range of motion decreased, Pain in extremity
Clinical narrative: Prolonged arm pain and limited ROM for 3 months. Multiple PT and massages appointments required to alleviate pain and resume ROM.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Pyrexia
Clinical narrative: One day later, pt has chills and fever post morning of shot.
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: Injection site reaction: rash, redness, painful, swollen.
Age: 25.0
Sex: F
Vaccine: FLU4, HEPA, TYP
Symptoms: Injected limb mobility decreased, Injection site pain, Loss of personal independence in daily activities, Pain in extremity
Clinical narrative: Client complains of pain/soreness in right arm after receiving the Hepatitis A injection on 12/10/18, client states that the injection was painful. Client complains that she had a great deal of difficulty moving her arm for about a week afterwards and interfered with some usual activities such as yoga and swimming. After the week, the pain improved but she continued to have difficulty lifting her right arm above her head. Client emailed clinic to inform of concern on 1/5/19. Clinic called client on 1/7/19 (first business day from receiving email) and left a voice-mail expressing concern. Clinic made return call to client on 1/8/19 and was able to reach her. Client had not yet seen a health care professional regarding the concern. Clinic advised client to seek treatment for the complaint with verbalized understanding.
Age: 20.0
Sex: F
Vaccine: FLUN4
Symptoms: Dystonia, Feeling abnormal, Gait inability, Headache, Hyperhidrosis
Clinical narrative: Patient c/o foggy brain, headache diaphoresis, seizures, spasmodic abasia, spasmodic dystonia and fever x 4 days. E.R.: Patient went to E.R. on 11/13/18. Patient stated she was told it was a virus and discharged home from E.R. Second E.R.: Patient also stated she went to E.R. but did not remember date or tests performed. Third E.R.: Patient went to another E.R. and sat for 8 hours without being seen by Physician so she left the facility. Hospital: Patient admitted at hospital x 2 days. Date and tests performed unknown.
Age: 20.0
Sex: F
Vaccine: FLUN4
Symptoms: Laboratory test, Pyrexia, Seizure, Viral infection
Clinical narrative: Patient c/o foggy brain, headache diaphoresis, seizures, spasmodic abasia, spasmodic dystonia and fever x 4 days. E.R.: Patient went to E.R. on 11/13/18. Patient stated she was told it was a virus and discharged home from E.R. Second E.R.: Patient also stated she went to E.R. but did not remember date or tests performed. Third E.R.: Patient went to another E.R. and sat for 8 hours without being seen by Physician so she left the facility. Hospital: Patient admitted at hospital x 2 days. Date and tests performed unknown.
Age: 13.0
Sex: F
Vaccine: FLU4, HEPA, HPV4
Symptoms: Blood glucose decreased, Cyanosis, Dysstasia, Fall, Fatigue
Clinical narrative: 5 - 10 minutes after vaccines administered patient stood and took 3 steps and fell into sink, was unconscious. We lowered to floor, color pale, lips and nail beds cyanotic, skin diaphoretic. Eyes open - staring. Pulse faint - respiratory shallow. 1-7-19, 1 PM, Patient vaccinated with Hep A, FLULAVAL and HPV (GARDASIL 9) in (L) thigh and (R) thigh per mother and patients request. Stated "That is where she always gets vaccine. 1:10 PM, Patient stood and took 3 steps and fell into sink, unconscious. We lowered her to floor and her eyes were open in a blank stare. Color pale - lips bluish - very shallow breathing - faint radial pulse - carotid pulse 60-70 regular. Skin diaphoretic. 1:15, Did a FSBS = 80. She is able to grip my hands weakly. Gave her a lollipop to suck on. She will not verbalize. Shakes her head yes and no. 1:20, Gave her some sips of soda. No nausea, still pale, hands cold - nail bed cyanotic. Moves all 4 extremities. Understands my commands and mother's. 1:30, Still will not verbalize. I called 911 to get help. 1:45, Still no change, still very pale and unable to stand or verbalize. EMT arrives - did pulse ox = 89%. Put her on O2 and lifted her onto cot for transport. 4 PM, I phoned mother, they were still at ER. Can't find anything abnormal. She is able to speak and much better. 1-8-19, 10 AM, Phoned mother - patient still tired and more quiet than usual. Otherwise OK. Home meds - FOCLAN 30 mg p.o. qd for ADHD, ZYRTEC 10 mg p.o. qd for headaches, B12 qd, Mag. oxide qd.